First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
Titel:
First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trial
Auteur:
Lee, Siow Ming Khan, Iftekhar Upadhyay, Sunil Lewanski, Conrad Falk, Stephen Skailes, Geraldine Marshall, Ernie Woll, Penella J Hatton, Matthew Lal, Rohit Jones, Richard Toy, Elizabeth Chao, David Middleton, Gary Bulley, Sue Ngai, Yenting Rudd, Robin Hackshaw, Allan Boshoff, Chris